Thus, the evidence suggests that PD-L1 level in tumours is an important factor influencing therapeutic efficacy for responders15–17, although the correlation is not perfect and the mechanisms underlying this correlation in non-responders have not been precisely revealed18. Here, CD274 is linked to neoplasm.